Where Can You Report Your Adverse Drug Reactions Or Adverse Events Following Immunization

اين يمكنك التبليغ عن الاحداث الجانية للأدوية واللقاحات

Where Can You Report your Adverse Drug Reactions or Adverse Events Following Immunization

This section provides a comprehensive overview of the procedures and tools available to Healthcare Professionals, Market Authorization Holders and the General Public to report adverse events associated with medicinal products and vaccines in Lebanon.

How to report

You can send the case reports using the following tools:

For Healthcare Professionals and the Public

The Lebanese National Pharmacovigilance Program has adapted two user-friendly tools: one for Adverse Drug Reactions (Vigimobile e-Reporting e-Form) and another for reporting Adverse Events Following Immunization (Vigimobile e-Form). Both tools may be accessed by healthcare professionals and the general public.

The VigiMobile e-Form and e-Reporting e-Form:

The VigiMobile e-Form and e-Reporting e-Form are the latest tools launched in January 2025 by the Lebanese National Pharmacovigilance Program. These digital platforms were introduced to enhance the reporting process, with the e-Reporting e-Form designed for Adverse Drug Reactions (ADRs) and the VigiMobile e-Form specifically for Adverse Events Following Immunization (AEFIs).

How to Download on Android Phones

Scan the QR Code by pressing the link
Click the three dots in the top-right corner
Choose Install app
VigiMobile e-Form/e-Reporting e-Form now appears as an app

How to Download on Apple IOS Phones

Scan the QR Code by pressing the link
Click on the share button
Add VigiMobile to the home screen
VigiMobile e-Form/e-Reporting e-Form now appears as an app

How to Download on Windows

Press on the link
Install from the Browser menu
VigiMobile e-Form/e-Reporting e-Form is now installed

Scan QR Codes to Report:

ADRs Following Medication Use	AEFIs Following Vaccine Use

Or use the following link: LNPVP: e-Reporting eForm	Or use the following link: LNPVP: VigiMobile eForm

Direct Contact with the Lebanese National Pharmacovigilance Program:

You may contact the Lebanese National Pharmacovigilance Program through:

Email Address:

pv@moph.gov.lb, pv.moph@gmail.com

Phone number of the Quality Assurance of Pharmaceutical Products Program: 01-830254

For Market Authorization Holders:

Based on the Ministerial Resolution MR #181 issued in 2021, MAHs should adhere to the internationally agreed ICH guidelines and standards and send the reports in XML format as specified in ICH E2B (R2 or R3) guidelines

(https://www.moph.gov.lb/userfiles/files/Quality%26Safety/PharmacovigilanceSystemInLebanon/Karar%20181-2021.pdf).

All XML files should be sent to the following emails: pv@moph.gov.lb, and pv.moph@gmail.com.

As for what to report or report type, you can refer to Module VI:
https://moph.gov.lb/en/Pages/4/44742/pharmacovigilance-system-lebanon#/en/view/70479/lebanese-guideline-on-good-pharmacovigilance-practices-lgvp-

...

161

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05BB01	R-SOL	G	Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86%		Injectable solution	205,933 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS L	G	Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:106.5 mmol/l, Sodium chloride - Na+:135 mmol/l		Injectable solution	L.L
C08CA01	HYPODIPINE 5	G	Amlodipine (besylate) - 5mg	5mg	Capsule	362,837 L.L
C09DB04	TWINCARD 80/5	G	Telmisartan - 80mg, Amlodipine - 5mg		Tablet	1,131,387 L.L
H02AB07	PREDNISONE	G	Prednisone - 10mg	10mg	Tablet, scored	386,515 L.L
J01DD13	CEFODOX	G	Cefpodoxime (proxetil) - 100mg/5ml	100mg/5ml	Powder for suspension	735,082 L.L
J02AC01	UNAZOL	G	Fluconazole - 150mg	150mg	Capsule	149,742 L.L
L01BC06	CAPECITABINE PHARMINICIO	G	Capecitabine - 500mg	500mg	Tablet, film coated	8,869,508 L.L
N02BE01	PARAMOL	G	Paracetamol - 120mg/5ml	120mg/5ml	Syrup, alcohol free	85,750 L.L
N05AE05	LAROZA	G	Lurasidone - 120mg	120mg	Tablet, film coated	5,548,726 L.L
R03BA02	BUDECORT 200	G	Budesonide - 200mcg/actuation	200mcg/actuation	Metered dose inhaler	808,993 L.L
S01AE06	TYMER	G	Gatifloxacin (sesquihydrate) - 3mg/ml	3mg/ml	Drops solution	427,342 L.L
A10BB12	GLIM	G	Glimepiride - 4mg	4mg	Tablet	628,918 L.L
B05BB01	SERUFLEX RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l		Injectable solution	204,554 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LM	G	Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l		Injectable solution	L.L
C08CA01	LOTENSE	G	Amlodipine (besylate) - 5mg	5mg	Capsule	388,370 L.L
C09DB06	LOSANET AM	G	Losartan potassium - 100mg, Amlodipine - 10mg		Tablet	1,044,358 L.L
D03BA	SERODASE	G	Serratiopeptidase - 5mg	5mg	Tablet, enteric coated	460,938 L.L
H02AB07	PREDICOR	G	Prednisone - 50mg	50mg	Tablet, scored	712,876 L.L
J01DD13	ZAKON	G	Cefpodoxime (proxetil) - 100mg/5ml	100mg/5ml	Powder for suspension	1,116,733 L.L
J02AC01	FLUCTOBAR	G	Fluconazole - 100mg/50ml	100mg/50ml	Injectable solution	522,755 L.L
L01BC06	CAPECITABINE SHILPA	G	Capecitabine - 500mg	500mg	Tablet, film coated	7,396,894 L.L
M02AA10	ACHONID GEL	G	Ketoprofen - 2.5%	2.5%	Gel	179,179 L.L
N02BE01	PAROL INFANTS	G	Paracetamol - 120mg/5ml	120mg/5ml	Syrup	281,567 L.L
N06AX26	LYTIOX	G	Vortioxetine - 20mg	20mg	Tablet, film coated	3,290,622 L.L
R03BA02	BUDENA	G	Budesonide - 200mcg/actuation	200mcg/actuation	Inhalation suspension	1,065,667 L.L
S01AE07	AROX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	423,310 L.L
A03FA07	GAROPRIDE	G	Itopride Hydrochloride - 50mg	50mg	Tablet, film coated	213,671 L.L
A10BB12	GLUMYL 4	G	Glimepiride - 4mg	4mg	Tablet	317,403 L.L
B05BB01	SOLUFLEX RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l		Injectable solution	221,792 L.L

...

161

...